Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8757523rdf:typepubmed:Citationlld:pubmed
pubmed-article:8757523lifeskim:mentionsumls-concept:C1513019lld:lifeskim
pubmed-article:8757523lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8757523lifeskim:mentionsumls-concept:C1867800lld:lifeskim
pubmed-article:8757523lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:8757523lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:8757523lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:8757523pubmed:issue1lld:pubmed
pubmed-article:8757523pubmed:dateCreated1996-9-26lld:pubmed
pubmed-article:8757523pubmed:abstractTextThe translocation t(1;19)(q23;p13) is found in 3-5% of all acute lymphoblastic leukaemias (ALL) and results in the expression of an E2A/PBX1 hybrid gene transcript. This translocation is very closely associated with a pre-B phenotype. t(14;18) is associated with follicular B-cell lymphoma and is characterized by over-expression of the bcl-2 oncogene. We describe a case of ALL in an adult with a mature B-cell immunophenotype and a single abnormal cell line with a complex karyotype showing both t(1;19) and t(14;18). Two reports of this phenomenon have been published previously and molecular analysis, where performed, showed the E2A gene was not rearranged, suggesting the t(1;19) was a molecular variant of the established translocation. In contrast, molecular analysis of our case demonstrated expression of the E2A/PBX1 fusion transcript typically associated with t(1;19) in pre-B ALL but showed it to be present at an extremely low level, despite the abnormal karyotype being found in the majority of metaphase cells. Analysis of bcl-2 expression showed a significant up-regulation. A down-regulation of the E2A/PBX1 hybrid gene as a consequence of the enhanced expression of bcl-2 may be a possible mechanism for this finding.lld:pubmed
pubmed-article:8757523pubmed:languageenglld:pubmed
pubmed-article:8757523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8757523pubmed:citationSubsetIMlld:pubmed
pubmed-article:8757523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8757523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8757523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8757523pubmed:statusMEDLINElld:pubmed
pubmed-article:8757523pubmed:monthJullld:pubmed
pubmed-article:8757523pubmed:issn0007-1048lld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:RoweDDlld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:HallA GAGlld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:TurnerG EGElld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:IrvineJ CJClld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:DevarajP EPElld:pubmed
pubmed-article:8757523pubmed:authorpubmed-author:HogarthLLlld:pubmed
pubmed-article:8757523pubmed:issnTypePrintlld:pubmed
pubmed-article:8757523pubmed:volume94lld:pubmed
pubmed-article:8757523pubmed:ownerNLMlld:pubmed
pubmed-article:8757523pubmed:authorsCompleteYlld:pubmed
pubmed-article:8757523pubmed:pagination133-5lld:pubmed
pubmed-article:8757523pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:meshHeadingpubmed-meshheading:8757523-...lld:pubmed
pubmed-article:8757523pubmed:year1996lld:pubmed
pubmed-article:8757523pubmed:articleTitleA case of mature B-cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene.lld:pubmed
pubmed-article:8757523pubmed:affiliationDepartment of Human Genetics, University of Newcastle upon Tyne.lld:pubmed
pubmed-article:8757523pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8757523pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8757523pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8757523lld:pubmed